Treos Bio Company

Treos Bio, Inc. develops precision cancer immunotherapies tailored to patients' genetics.
Technology: Peptides and Proteins
Industry: Deep diagnostics
Headquarters: London, England, United Kingdom
Founded Date: 2013-01-01
Employees Number: 1-10
Funding Status: Early Stage Venture
Investors Number: 4
Total Funding: 22406704
Estimated Revenue: $1M to $10M
Last Funding Date: 2021-03-31
Last Funding Type: Convertible Note

Visit Website
info@treosbio.com
Register and Claim Ownership